So I have been thinking about how it is said that the trials are "double blinded", that no one knows who is getting the treatment vs the placebo, and I am thinking that if a treatment is not effective, then participants would be passing away, so it would behoove the company and the FDA to stop the trial in an attempt to preserve life, and instead move them to SOC.
Since that is not happening, then it appears that the treatments are working, so perhaps they are on the road to approval - RLFTF and CYDY.